Skip to main navigation Skip to search Skip to main content

Study Data from University of Leipzig Medical Center Update Knowledge of Disease Progression [Safety and Efficacy of Leriglitazone for Preventing Disease Progression In Men With Adrenomyeloneuropathy (Advance): a Randomised, Double-blind, ...]

Press/Media: Research

PeriodMar 22 2023

Media coverage

1

Media coverage

  • TitleStudy Data from University of Leipzig Medical Center Update Knowledge of Disease Progression [Safety and Efficacy of Leriglitazone for Preventing Disease Progression In Men With Adrenomyeloneuropathy (Advance): a Randomised, Double-blind, ...]
    Media name/outletDisease Prevention Daily
    Country/TerritoryUnited States
    Date3/22/23
    PersonsAli M. Fatemi